These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10585312)

  • 21. Variable effects of prevalence correction of population denominators on differentials in myocardial infarction incidence: a record linkage study in Aboriginal and non-Aboriginal Western Australians.
    Katzenellenbogen JM; Sanfilippo FM; Hobbs MS; Briffa TG; Ridout SC; Knuiman MW; Dimer L; Taylor KP; Thompson PL; Thompson SC;
    J Clin Epidemiol; 2011 Jun; 64(6):658-66. PubMed ID: 21109397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Singapore Renal Registry: an overview.
    Woo KT
    Singapore Med J; 1993 Apr; 34(2):157-63. PubMed ID: 8266160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic renal failure after transplantation of a nonrenal organ.
    Ojo AO; Held PJ; Port FK; Wolfe RA; Leichtman AB; Young EW; Arndorfer J; Christensen L; Merion RM
    N Engl J Med; 2003 Sep; 349(10):931-40. PubMed ID: 12954741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. End-stage renal disease in the Asian-Pacific region.
    Lee G
    Semin Nephrol; 2003 Jan; 23(1):107-14. PubMed ID: 12563605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Predictors of early death during dialysis].
    Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
    Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney transplant outcomes in the indigenous population in the Northern Territory of Australia.
    Rogers NM; Lawton PD; Jose MD
    Transplantation; 2006 Oct; 82(7):882-6. PubMed ID: 17038901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions.
    Port FK
    Kidney Int Suppl; 1995 Aug; 50():S3-6. PubMed ID: 8544432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality rates among patients with end-stage renal disease in Canada, 1981-86.
    Silins J; Fortier L; Mao Y; Posen G; Ugnat AM; Brancker A; Gaudette L; Wigle D
    CMAJ; 1989 Oct; 141(7):677-82. PubMed ID: 2790603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Using Dialysis and Transplantation Registries for regional and small-area epidemiology].
    Vitullo F
    G Ital Nefrol; 2003; 20(2):151-9. PubMed ID: 12746800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of ESRD treated with renal dialysis in France in 2003.
    Macron-Noguès F; Vernay M; Ekong E; Thiard B; Salanave B; Fender P; Allemand H
    Am J Kidney Dis; 2005 Aug; 46(2):309-15. PubMed ID: 16112050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of pre-existing end-stage renal disease on survival in acutely injured trauma patients.
    Lorelli DR; Kralovich KA; Seguin C
    Am Surg; 2001 Jul; 67(7):693-6. PubMed ID: 11450792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
    Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
    Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of cancer in kidney transplantation waiting list patients: a single center experience.
    Mosconi G; Stalteri L; Centofanti F; Capelli I; Carretta E; Persici E; Ubaldi G; Battaglino G; Raimondi C; Scolari MP; Stefoni S
    Transplant Proc; 2011 May; 43(4):1003-5. PubMed ID: 21620036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morbidity burden of end-stage kidney disease in Australia: hospital separation rates among people receiving kidney replacement therapy.
    McDonald SP; Tong B
    Nephrology (Carlton); 2011 Nov; 16(8):758-66. PubMed ID: 21707839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the total prevalence and incidence of end-stage kidney disease among Aboriginal and non-Aboriginal populations in the Northern Territory of Australia, using multiple data sources.
    Li L; Guthridge S; Li SQ; Zhao Y; Lawton P; Cass A
    BMC Nephrol; 2018 Jan; 19(1):15. PubMed ID: 29334912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brazilian dialysis census, 2009.
    Sesso Rde C; Lopes AA; Thomé FS; Lugon JR; Burdmann Ede A
    J Bras Nefrol; 2010 Dec; 32(4):374-8. PubMed ID: 21541452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2010 report of the Brazilian dialysis census.
    Sesso RC; Lopes AA; Thomé FS; Lugon JR; Santos DR
    J Bras Nefrol; 2011 Dec; 33(4):442-7. PubMed ID: 22189808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.